No significant association was demonstrated for PJI following total knee arthroplasty or for revision procedures, and GLP-1 therapy was not linked to increased rates of venous thromboembolism, acute kidney injury, cerebrovascular events, myocardial infarction, or hypoglycaemia. The gene discussed is GCG; the disease is venous thromboembolism.